UNLOCKING THE VALUE OF MRNA Trademark

Trademark Overview


On Friday, August 26, 2016, a trademark application was filed for UNLOCKING THE VALUE OF MRNA with the United States Patent and Trademark Office. The USPTO has given the UNLOCKING THE VALUE OF MRNA trademark a serial number of 87152225. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 26, 2018. This trademark is owned by PhaseRx, Inc.. The UNLOCKING THE VALUE OF MRNA trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations, namely, therapeutic synthetic messenger RNA (mRNA) and delivery agents comprised of lipid nanoparticle carriers and synthetic polymers for the delivery of mRNA to human tissue

Medical and scientific research in the fields of pharmaceuticals, biologics, drug delivery and medical therapeutics for others; product research and development for others in the fields of pharmaceutical formulations of macromolecules, macromolecular pharmaceutical products, macromolecular therapeutics, and delivery of macromolecular therapeutics
unlocking the value of mrna

General Information


Serial Number87152225
Word MarkUNLOCKING THE VALUE OF MRNA
Filing DateFriday, August 26, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 26, 2018
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 27, 2017

Trademark Statements


Goods and ServicesPharmaceutical preparations, namely, therapeutic synthetic messenger RNA (mRNA) and delivery agents comprised of lipid nanoparticle carriers and synthetic polymers for the delivery of mRNA to human tissue
Goods and ServicesMedical and scientific research in the fields of pharmaceuticals, biologics, drug delivery and medical therapeutics for others; product research and development for others in the fields of pharmaceutical formulations of macromolecules, macromolecular pharmaceutical products, macromolecular therapeutics, and delivery of macromolecular therapeutics

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, September 1, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, September 1, 2016
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePhaseRx, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSeattle, WA 98119

Party NamePhaseRx, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSeattle, WA 98119

Trademark Events


Event DateEvent Description
Monday, March 26, 2018ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, March 26, 2018ABANDONMENT - NO USE STATEMENT FILED
Tuesday, August 22, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 27, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 27, 2017PUBLISHED FOR OPPOSITION
Wednesday, June 7, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, May 17, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 16, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, May 16, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 16, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, December 12, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, December 12, 2016NON-FINAL ACTION E-MAILED
Monday, December 12, 2016NON-FINAL ACTION WRITTEN
Tuesday, December 6, 2016ASSIGNED TO EXAMINER
Thursday, September 1, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, August 30, 2016NEW APPLICATION ENTERED IN TRAM